Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2007-12-25
2007-12-25
Canella, Karen A. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S006120, C435S007100
Reexamination Certificate
active
10274609
ABSTRACT:
Materials and methods are disclosed for modulating proliferation of cell types associated with Hodgkin's disease through inhibition of IL-13 and components in IL-13 associated signal transduction pathways. Methods to identify inhibitors, compositions comprising the inhibitors, and methods using the inhibitors to treat Hodgkin's disease are also disclosed.
REFERENCES:
patent: WO 93/11236 (1993-06-01), None
Tolcher et al (Clinical Cancer Research, 2002, vol. 8, pp. 2530-2535).
Cripps et al (Clinical Cancer Research. 2002, 8, pp. 2188-2192).
Marshall et al (Clinical Colorectal Cancer, 2004, vol. 4, pp. 268-274).
Oza et al (Gynecological Oncology, 2003, vol. 89, pp. 129-133).
James and Gibson (Blood, 1998, vol. 91, pp. 371-382).
Schultze et al (Trends in Immunology, 2004, vol. 25, pp. 659-664).
Bodey et al, (Anticancer Research, 2000, vol. 20, pp. 2665-2676).
Vile et al (Gene Therapy, 2000, vol. 7, pp. 2-8).
Bramlage, et al., “Designing ribozymes for the inhibition of gene expression,” Trends in Biotech 16:434-438 (1998).
Cane, “Harnessing the Biosynthetic Code: Combinations, Permutations, and Mutations,” Science 282:63-68 (1998).
Cossman, et al., “Reed-Sternberg Cell: Survival in a Hostile Sea,” Lab. Invest. 78:229-235 (1998).
Del Prete, et al., “CD30-mediated Signalilng Promotes the Development of Human T Helper Type 2-like Cells,” J. Exp. Med. 182:1655-1661 (1995).
Doucet, et al., “Interleukin (IL) 4 and IL-13 Act on Human Lung Fibroblasts,” J. Clin Invest 101:2129-2139 (1998).
Drexler, “Recent Results on the Biology of Hodgkin and Reed-Sternberg Cells. I. Biopsy Material,” Leukemia and Lymphoma 8:283-313 (1992).
Drexler, “Recent Results on the Biology of Hodgkin and Reed-Sternberg Cells,” Leukemia and Lymphoma 9:1-25 (1993).
Emson, et al., “Interleukin (IL)-4-independent Induction of Immunoglobulin (Ig)E, and Perturbation of T Cell Development in Transgenic Mice Expressing IL-13,” J. Exp. Med. 188:299-404 (1998).
Fonatsch, et al., “Assignment of the Human CD30 (Ki-1) Gene to 1p36,” Genomics 14:825-826 (1992).
Gibson, et al., “Ribozymes,” Mol. Biotech. 7:125-137 (1997).
Harlow, et al., Antibodies A Laboratory Manual Chapter 6 (1988).
Hui, et al., “A mouse model of Greig cephalo-polysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the Gli3 gene,” Nat. Genet. 3:241-246, 1993.
Ikushim, et al., “Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes,” Proc. Natl. Acad. Sci. USA 94:2609-2614 (1997).
Kadin, “Pathology of Hodgkin's disease,” Current Opinion in Oncology 6:456-463 (1994).
Kanzler, et al., “Hodgkin and Reed-Sternberg Cells in Hodgkin's Disease Represent the Outgrowth of a Dominant Tumor Clone Derived from (Crippled) Germinal Center B Cells,” J. Exp Med. 184:1495-1505 (1996).
Küppers, et al., “The Origin of Hodgkin and Reed/Sternberg Cells in Hodgkin's Disease,” Annu Rev Immunol 16:471-491 (1998).
Larsson, et al., “The Human NOTCH1, 2, and 3 Genes Are Located at Chromosome Positions 9q34, 1p13-p11, and 19013.2-p13.1 in Regions of Neoplasia-Associated Translocation,” Genomics 24:253-258 (1994).
Lavrovsky, et al., “Therapeutic Potential and Mechanism of Action of Oligonucleotides and Ribozymes,” Biochem. Mol. Med. 62:11-22 (1997).
Lin, et al., “The Role of Shared Receptor Motifs and Common Stat Proteins in the Generation of Cytokine Pleiotropy and Redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15,” Immunity 2:331-339 (1995).
McKenzie, et al., “Impaired Development of Th2 Cells in IL-13 Deficient Mice,” Immunity 9:423-432 (1998).
Minty, et al., “Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses,” Nature 362:248-250 (1993).
Myers, “Will Combinatorial Chemistry deliver real medicines?” Curr. Opion. Biotechnol. 8:701-707 (1997).
Robey, “Notch in vertebrates,” Curr. Opin. Genet. Dev. 7:551-557 (1997).
Samoszuk, et al., “Detection of Interleukin-5 Messenger RNA in Reed-Sternberg Cells of Hodgkin's Disease With Eosinophilia,” Blood 75:13-16 (1990).
Samoszuk, et al., “IgE in Reed-Sternberg Cells of Hodgkin's Disease With Eosinophilia,” Blood 79:1518-1522 (1992).
Schena, et al., “Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray,” Science 270:467-470 (1995).
Schena, et al., “Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes,” Proc. Natl. Acad. Sci. USA 93:10614-10619 (1996).
Shahinian, et al., “Differential T Cell Costimulatory Requirements in CD28-Deficient Mice,” Science 261:609-612 (1993).
Shalon, et al., “A DNA Microarray System for Analyzing Complex DNA Samples Using Two-color Fluorescent Probe Hybridization,” Genome Res. 6:639-645 (1996).
Thangavelu, et al., “Chromosomal Abnormalities in Hodgkin's Disease,” Hematol. Oncol. Clin. North Am 3:221-236 (1984).
Thomas, et al., “IgE Levels in Hodgkin's Disease,” Ann Allergy 37:416-419 (1976).
Zurawski, et al., “Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells,” Immunology Today 15:19-26 (1994).
Kapp Ursula
Mak Tak W.
Amgen Canada Inc.
Canella Karen A.
LandOfFree
Materials and methods to inhibit Hodgkin and Reed Sternberg... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Materials and methods to inhibit Hodgkin and Reed Sternberg..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods to inhibit Hodgkin and Reed Sternberg... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3870321